Referral for the group of younger patients is important because young age at diagnosis of breast cancer indicates a higher risk to carry a BRCA1 or BRCA2 pathogenic variant and is a clear indication for referral to breast cancer genetic testing [44]. The gene discussed is BRCA2; the disease is breast cancer.